Atelvia

Common Brands Atelvia​
Drug Class
Bisphosphonate
Controlled Substance Classification
Not a controlled medication
Generic Status
Lower-cost generic available
Availability
Prescription only
Shifali Patel, PharmD
Shifali Patel, PharmD
Read More
Medically reviewed by Shifali Patel, PharmD last update on 20/12/2023

Overview

Atelvia is a medication that is mainly prescribed for the treatment and prevention of osteoporosis, which is a medical condition that makes bones weak and fragile. It belongs to a class of medications known as bisphosphonates, the effect of which can be explained as blocking the action of cells responsible for bone resorption (osteoclasts). 

Atelvia is especially useful for women after the menopause who are suffering from osteoporosis as it decreases the chances of suffering from fractures by increasing the bone mass.

 

The active drug in Atelvia is risendronate sodium, an oral bisphosphonate. It is prepared as a delayed release tablet, i.e., the active ingredient where the drug is available in the system is released over a prolonged period, which in turn helps in minimizing the adverse effects of the gastrointestinal system associated with other bisphosphonates.

DRUG STATUS

Availability

Prescription only

Pregnancy & Lactation

Pregnancy